United Therapeutics(DE:UTH)
€539.20+4.20 (+0.79%)
DE:UTH
United Therapeutics earnings date
€539.20
At close:+4.20 (+0.79%)
United Therapeutics (UTH) Q1 2026 Earnings Report
4 Followers
DE:UTH Q1 2026 EPS Results
- Actual EPS
- EUR 5.21
- Consensus EPS
- EUR 6.27
- Beat/Miss
- Missed by -EUR 1.05
- One Year Ago EPS
- EUR 5.94
DE:UTH Q1 2026 Revenue Results
- Actual Revenue
- EUR 699.72M
- Expected Revenue
- EUR 713.96M
- Beat/Miss
- Missed by -EUR 14.24M
- YoY Revenue Growth
- -1.62%
Earnings Announcement Details
- Quarter
- Q1 2026
- Date
- 05/06/2026
- Time
- Before Open
- Conference Call
- Wednesday, May 6, 2026
DE:UTH Upcoming Earnings
United Therapeutics's next earnings date is estimated for February 24, 2027, based on past reporting schedules.
Q1 2026 Earnings Call Audio
DE:UTH Q1 2026 Earnings Call
0:00 / 0:00
Q1 2026 Earnings Slide Deck
Q1 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:UTH Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 24, 2027 | 2026 (Q4) | 4.43- | 6.89 | ― | ― |
| Nov 04, 2026 | 2026 (Q3) | 5.385.11 | 6.41 | -20.25% (-1.30) | |
| Aug 05, 2026 | 2026 (Q2) | 6.146.51 | 5.74 | 13.42% (+0.77) | |
| May 06, 2026 | 2026 (Q1) | 6.275.21 | 5.94 | -12.22% (-0.73) | |
| Feb 25, 2026 | 2025 (Q4) | 6.386.89 | 5.54 | 24.39% (+1.35) | |
| Oct 29, 2025 | 2025 (Q3) | 6.556.41 | 5.72 | 12.05% (+0.69) | |
| Jul 30, 2025 | 2025 (Q2) | 6.535.74 | 5.24 | 9.57% (+0.50) | |
| Apr 30, 2025 | 2025 (Q1) | 6.005.94 | 5.52 | 7.46% (+0.41) | |
| Feb 26, 2025 | 2024 (Q4) | 5.735.54 | 3.9 | 41.97% (+1.64) | |
| Oct 30, 2024 | 2024 (Q3) | 5.845.72 | 4.82 | 18.77% (+0.90) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
